CASP8 and osteosarcoma: As a potent diphenyldihaloketone analog, CLEFMA not only induces apoptosis of human osteosarcoma U2OS and HOS cells but also triggers activation of the caspase cascade of caspases 8 and 9 initiators and the caspase 3 effector in U2OS cells 165.